This paper presents a summary of primary prevention measures for atherosclerotic cardiovascular disease caused by elevated low-density lipoprotein cholesterol, and other cardio-metabolic risk factors such as obesity and diabetes, as well as hypertension.
Serie de videos en español con especialistas en ASCVD para discusión sobre el riesgo cardiovascular en América Latina.
Serie de videos en español con especialistas en ASCVD para discusión sobre la quilomicronemia familiar en América Latina.
Peter Libby, MD, and Jessica M. Peña, MD, MPH, FACC, FNLA, discuss the role that inflammation plays in atherosclerosis.
A contemporary perspective on the assessment and management of cardiovascular risk due to elevated triglycerides.
A clinical proceedings white paper that outlines the role of inflammation in atherosclerosis and the importance of early intervention.
First infographic of the series based on the “Approaches for Management of Statin Intolerant Patients” webinar.
Second infographic of the series based on the “Approaches for Management of Statin Intolerant Patients” webinar.
Third infographic of the series based on the “Approaches for Management of Statin Intolerant Patients” webinar.
Fourth infographic of the series based on the “Approaches for Management of Statin Intolerant Patients” webinar.
Experts review the mechanics of LDL and its causal relationship with atherogenesis, outline the burden of statin intolerance, and share recent research findings concerning bempedoic acid.
This guidance provided by IAS member society JAS gives recommendations on the prevention of ASCVD.
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
